|
Genes
|
Per se
|
LL
|
Borderline
|
TT
|
Controls
|
|---|
|
N = 408
|
N = 21
|
N = 302
|
N = 60
|
N = 413
|
|---|
|
n (%)
|
n (%)
|
n (%)
|
n (%)
|
n (%)
|
|---|
|
KIR2DL1
|
355 (87.0)a
|
19 (90.4)
|
260 (86.0)a
|
56 (93.3)
|
397 (96.2)a
|
|
KIR2DL2
|
290 (72.0)
|
14 (66.6)
|
209 (69.2)
|
48 (80.0)
|
300 (72.6)
|
|
KIR2DL3
|
363 (88.9)
|
18 (85.7)
|
272 (90.0)
|
53 (88.3)
|
380 (92.0)
|
|
KIR2DL4
|
405 (99.2)
|
21 (100)
|
300 (99.3)
|
60 (100)
|
409 (99.0)
|
|
KIR2DL5
|
227 (55.6)
|
8 (38.0)
|
167 (55.2)
|
36 (60.0)
|
225 (54.4)
|
|
KIR3DL1
|
388 (95.0)
|
21 (100)
|
286 (94.7)
|
58 (96.6)
|
392 (94.9)
|
|
KIR3DL2
|
405 (99.2)
|
21 (100)
|
301 (99.6)
|
59 (98.3)
|
413 (100)
|
|
KIR3DL3
|
406 (99.5)
|
21 (100)
|
301 (99.6)
|
60 (100)
|
413 (100)
|
|
KIR2DS1
|
151 (37.0)
|
5 (23.8)
|
112 (37.0)
|
25 (41.6)
|
156 (37.7)
|
|
KIR2DS2
|
215 (52.6)
|
10 (47.6)
|
159 (52.6)
|
30 (50.0)
|
197 (47.6)
|
|
KIR2DS3
|
123 (30.1)
|
4 (19.0)
|
90 (29.8)
|
19 (31.6)
|
129 (60.5)
|
|
KIR2DS4
|
387 (94.8)
|
21 (100)
|
286 (94.7)
|
57 (95.0)
|
386 (93.4)
|
|
KIR2DS5
|
144 (35.2)
|
5 (23.8)
|
107 (35.4)
|
23 (38.3)
|
157 (38.0)
|
|
KIR3DS1
|
148 (36.2)
|
4 (19.0)b
|
107 (35.4)
|
26 (43.3)b
|
153 (37.0)
|
-
NOTE: Data represent the number of KIR genes and values in parentheses correspond to the percentages of each gene. TT: Tuberculoid, Borderline (BL, BB, BT), LL: Lepromatous.
-
a
KIR2DL1: P < 0.001, Pc < 0.014, OR = 0.26 (0.15 – 0.48) to per se vs. controls P < 0.001, Pc < 0.014, OR = 0.24 (0.13 – 0.45) to Borderline vs. controls.
-
b
KIR3DS1: P = 0.07 (tendency) to TT vs. LL.
